Boston Scientific Corporation (BSX) - Winst- en verliesrekening

Home
BSX
Financiële Gegevens

102.95 (USD) • At close August 6, 2025

Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.

	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005	2004	2003	2002	2001	2000	1999	1998	1997	1996	1995	1994	1993	1992	1991
Omzet Numbers are in millions	16,747	14,240	12,682	11,888	9,913	10,735	9,823	9,048	8,386	7,477	7,380	7,143	7,249	7,622	7,806	8,188	8,050	8,357	7,821	6,283	5,624	3,476	2,919	2,673	2,664	2,842	2,233.6	1,872.3	1,462	1,107	448.9	380.1	315.2	230
Kosten van de omzet Numbers are in millions	6,480	5,409	4,968	4,427	4,337	3,856	3,346	3,177	3,043	2,835	2,720	2,608	2,689	2,940	3,019	3,012	2,960	2,958	2,737	1,538	1,347	961	870	919	742	900	658.9	463.7	339.6	277	153.1	133.9	111.9	78.4
Brutowinst Numbers are in millions	10,267	8,831	7,714	7,461	5,576	6,879	6,477	5,871	5,343	4,564	4,588	4,535	4,560	4,682	4,787	5,176	5,090	5,399	5,084	4,745	4,277	2,515	2,049	1,754	1,922	1,942	1,574.7	1,408.6	1,122.4	830	295.8	246.2	203.3	151.6
Brutowinstmarge Numbers are in millions	0.686	0.695	0.684	0.684	0.646	0.704	0.707	0.706	0.702	0.7	0.686	0.676	0.655	0.651	0.667	0.685	0.693	0.72	0.718	0.779	0.77	0.724	0.702	0.656	0.721	0.683	0.705	0.752	0.768	0.75	0.659	0.648	0.645	0.659
Onderzoek- en ontwikkelingskosten Numbers are in millions	1,615	1,414	1,323	1,204	1,143	1,174	1,113	997	920	876	817	861	886	895	939	1,032	999	1,089	1,008	680	569	452	343	275	199	197	882.2	196.7	0	0	29.5	0	0	0
Algemene en administratieve kosten Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1,171	1,002	961	867	842	786.3	710.4	719.2	505	127.2	131.2	105.9	77.7
Verkoop- en marketingkosten Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-226	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Verkoop-, algemene en administratieve kosten Numbers are in millions	5,984	5,190	4,520	4,286	3,787	3,928	3,557	3,281	3,083	2,847	2,878	2,651	2,519	2,483	2,575	2,621	2,558	2,905	2,610	1,814	1,742	1,171	1,002	961	867	842	786.3	710.4	719.2	505	127.2	131.2	105.9	77.7
Overige kosten Numbers are in millions	33	46	47	49	45	-65	-70	-68	-104	-51	-48	-152	-161	-181	-200	-220	-238	-225	-231	-227	-195	158	9	136	181	178	128.6	86.7	61.4	40	9.1	6.4	4.6	3.4
Bedrijfskosten Numbers are in millions	7,632	6,650	5,890	5,539	4,975	5,167	4,740	4,346	4,107	3,774	3,743	3,664	3,566	3,559	3,714	3,873	3,795	4,219	3,849	2,721	2,506	1,781	1,354	1,372	1,247	1,217	1,797.1	993.8	780.6	545	165.8	137.6	110.5	81.1
Bedrijfsresultaat Numbers are in millions	2,635	2,181	1,824	1,922	601	1,712	1,737	1,525	1,236	790	845	871	994	1,123	1,073	1,303	1,295	1,180	1,235	2,024	1,771	697	610	100	675	725	-222.4	414.8	341.8	285	130	108.6	92.8	70.5
Bedrijfsresultaat ratio Numbers are in millions	0.155	0.165	0.13	0.172	0.105	0.141	0.153	0.142	0.053	-0.044	0.041	0.017	-0.534	0.119	-0.084	-0.109	-0.191	-0.002	-0.377	0.154	0.28	0.201	0.209	0.037	0.253	0.255	-0.1	0.222	0.234	0.257	0.29	0.286	0.294	0.307
Totaal overige inkomsten en kosten netto Numbers are in millions	-353	-196	-683	-846	-680	-1,025	-315	-592	-1,059	-1,440	-1,354	-1,094	-5,101	-481	-2,136	-2,611	-3,326	-1,749	-4,770	-1,133	-277	-54	-61	-56	-148	-163	-766	-207	-38.5	-193.8	-1	0.9	-1.3	-2.7
Inkomen voor belasting Numbers are in millions	2,282	1,985	1,141	1,076	-79	687	1,422	933	177	-650	-509	-223	-4,107	642	-1,063	-1,308	-2,031	-569	-3,535	891	1,494	643	549	44	527	562	-275.3	258.7	297	85	128.9	109.5	91.5	67.8
Inkomen voor belasting ratio Numbers are in millions	0.136	0.139	0.09	0.091	-0.014	0.064	0.145	0.103	0.021	-0.087	0.012	-0.031	-0.567	0.084	-0.136	-0.16	-0.256	-0.068	-0.452	0.142	0.266	0.185	0.188	0.016	0.198	0.198	-0.123	0.138	0.203	0.077	0.287	0.288	0.29	0.295
Belastingkosten Numbers are in millions	436	393	443	36	2	-4,013	-249	828	-170	-411	-176	-102	-39	201	2	-283	10	-74	42	263	432	171	176	98	154	191	-10.9	98.3	129.9	77	49.2	39.8	34.9	26.3
Nettowinst Numbers are in millions	1,854	1,593	698	1,040	-82	4,700	1,671	104	347	-239	-119	-121	-4,068	441	-1,065	-1,025	-2,036	-495	-3,577	628	1,062	472	373	-54	373	371	-264.4	139.3	167.1	8	79.7	69.7	56.6	41.8
Nettowinstmarge Numbers are in millions	0.111	0.112	0.055	0.088	-0.014	0.438	0.17	0.011	0.041	-0.032	0.036	-0.017	-0.561	0.058	-0.136	-0.125	-0.257	-0.059	-0.457	0.1	0.189	0.136	0.128	-0.02	0.14	0.131	-0.118	0.074	0.114	0.007	0.178	0.183	0.18	0.182
WPA (Winst Per Aandeel) Numbers are in millions	1.259	1.081	0.449	0.693	-0.081	3.378	1.21	0.08	0.26	-0.18	-0.09	-0.09	-2.89	0.29	-0.7	-0.68	-1.36	-0.33	-2.81	0.76	1.27	0.57	0.46	-0.065	0.46	0.46	-0.34	0.18	0.22	0.011	0.19	0.18	0.14	0.11
Verwaterde WPA Numbers are in millions	1.247	1.073	0.446	0.687	-0.081	3.332	1.19	0.075	0.25	-0.18	-0.09	-0.09	-2.89	0.29	-0.7	-0.68	-1.36	-0.33	-2.81	0.75	1.24	0.56	0.45	-0.065	0.45	0.45	-0.34	0.17	0.21	0.011	0.19	0.18	0.14	0.11
EBITDA Numbers are in millions	3,938	3,453	2,741	2,518	1,511	2,210	2,585	2,007	1,226	360	433	721	-3,161	1,635	149	-108	-699	940	-2,319	1,295	1,833	930	856	614	856	903	620	509	411.8	299.9	139	115	97.4	73.9
EBITDA ratio Numbers are in millions	0.23	0.242	0.216	0.212	0.152	0.206	0.263	0.222	0.146	0.048	0.059	0.101	-0.436	0.215	0.019	-0.013	-0.087	0.112	-0.297	0.206	0.326	0.268	0.293	0.23	0.321	0.318	0.278	0.272	0.282	0.271	0.31	0.303	0.309	0.321

Boston Scientific Corporation

NYSE:BSX Add to watchlist

NYSE:BSX